Weighted Average Number of Shares Outstanding, Basic of Sonoma Pharmaceuticals, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Sonoma Pharmaceuticals, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Sonoma Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 1,713,000, a 17% increase year-over-year.
  • Sonoma Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 1,241,000, a 173% increase from 2023.
  • Sonoma Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 455,000, a 87% decline from 2022.
  • Sonoma Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3,394,000.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Sonoma Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,713,000 +249,000 +17% 01 Oct 2025 31 Dec 2025 10-Q 10 Feb 2026 2026 Q3
Q3 2025 1,646,000 +612,000 +59% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2026 Q2
Q2 2025 1,641,000 +790,000 +93% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q1 2025 1,241,000 +786,000 +173% 01 Jan 2025 31 Mar 2025 10-K 17 Jun 2025 2025 FY
Q4 2024 1,464,000 +918,000 +168% 01 Oct 2024 31 Dec 2024 10-Q 10 Feb 2026 2026 Q3
Q3 2024 1,034,000 +776,000 +301% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2026 Q2
Q2 2024 851,000 -4,085,000 -83% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2026 Q1
Q1 2024 455,000 -2,939,000 -87% 01 Jan 2024 31 Mar 2024 10-K 17 Jun 2025 2025 FY
Q4 2023 546,000 -2,561,000 -82% 01 Oct 2023 31 Dec 2023 10-Q 05 Feb 2025 2025 Q3
Q3 2023 258,000 +254,899 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2025 Q2
Q2 2023 4,936,000 +4,932,899 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2025 Q1
Q1 2023 3,394,000 01 Jan 2023 31 Mar 2023 10-K 17 Jun 2024 2024 FY
Q4 2022 3,107,000 +3,103,920 01 Oct 2022 31 Dec 2022 10-Q 08 Feb 2024 2024 Q3
Q3 2022 3,101* +757 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2024 Q2
Q2 2022 3,101* -2,089,899 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2024 Q1
Q4 2021 3,080* +1,028 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q3
Q3 2021 2,344* -2,005,656 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q2
Q2 2021 2,093,000 +254,000 +14% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2023 Q1
Q4 2020 2,052* 01 Oct 2020 31 Dec 2020 10-Q 11 Feb 2022 2022 Q3
Q3 2020 2,008,000 +691,000 +52% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2022 Q2
Q2 2020 1,839,000 +523,000 +40% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2022 Q1
Q3 2019 1,317,000 01 Jul 2019 30 Sep 2019 10-Q 20 Nov 2020 2021 Q2
Q2 2019 1,316,000 +623,000 +90% 01 Apr 2019 30 Jun 2019 10-Q/A 17 Nov 2020 2021 Q1
Q2 2018 693,000 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2020 Q1
Q4 2017 4,392,000 +167,000 +4% 01 Oct 2017 31 Dec 2017 10-Q 14 Feb 2018 2018 Q3
Q4 2016 4,225,000 +932,000 +28% 01 Oct 2016 31 Dec 2016 10-Q 14 Feb 2018 2018 Q3
Q4 2015 3,293,000 01 Oct 2015 31 Dec 2015 10-Q 17 Feb 2017 2017 Q3
Q4 2011 27,020,000 +589,000 +2.2% 01 Oct 2011 31 Dec 2011 10-Q 10 Feb 2012 2011 Q3
Q4 2010 26,431,000 01 Oct 2010 31 Dec 2010 10-Q 10 Feb 2012 2011 Q3

Sonoma Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 1,241,000 +786,000 +173% 01 Apr 2024 31 Mar 2025 10-K 17 Jun 2025 2025 FY
2023 455,000 -2,939,000 -87% 01 Apr 2023 31 Mar 2024 10-K 17 Jun 2025 2025 FY
2022 3,394,000 +3,391,347 01 Apr 2022 31 Mar 2023 10-K 17 Jun 2024 2024 FY
2021 2,653* 01 Apr 2021 31 Mar 2022 10-K 21 Jun 2023 2023 FY
2014 9,657,000 +2,775,000 +40% 01 Apr 2014 31 Mar 2015 10-K 16 Jun 2015 2015 FY
2013 6,882,000 +1,905,000 +38% 01 Apr 2013 31 Mar 2014 10-K 16 Jun 2015 2015 FY
2012 4,977,000 01 Apr 2012 31 Mar 2013 10-K 30 Jun 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.